Sunbird Bio
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
35 Cambridgepark Dr Ste 100, Cambridge, ...Phone Number
(857) 242-0034Website
www.sunbirdbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Sunbird Bio
Sunbird Bio is a biotech company specializing in the development of protein-based diagnostic tests aimed at enhancing the diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The company is pioneering blood-based diagnostic technology that allows for the direct detection of specific proteins associated with neurodegenerative diseases, facilitating earlier and more accurate diagnoses. Their innovative platform is designed to provide comprehensive diagnostic insights, enabling precision neurology and improving patient outcomes. Sunbird Bio's focus on overcoming diagnostic limitations positions it as a leader in the field of blood-based diagnostics for neurological diseases.Explore more
Sunbird Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sunbird Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Sunbird Bio has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Sunbird Bio has new funding data
Click to see if Sunbird Bio had a recent Job posting/layoffs
Product Launch: Get notified when Sunbird Bio launches new products
Sunbird Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Sunbird Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Sunbird Bio
Earning: See what the market has to say on Sunbird Bio recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Sunbird Bio
Compare insights from companies similar to Sunbird Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sunbird Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sunbird Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sunbird Bio.
Sunbird Bio financials insights
Gather financial insights about Sunbird Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$14M
Sunbird Bio Tech Stack
A closer look at the technologies used by Sunbird Bio
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Event
Project
Events, Event Marketing, Medical Research, Clinical Operations, Marketing Strategy
Funding
Funding
Mergers & Acquisitions (M&A)
Sunbird Bio News & Media
Sunbird Bio Appoints Richard Batrla, M.D., Ph.D., MBA as Chief Medical Officer
CAMBRIDGE, Mass. & SINGAPORE--(BUSINESS WIRE)--Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, today announced the appointment of Richard Batrla, M.D., Ph.D., MBA as chief medical officer. “There couldn’t be a better time to welcome Richard to the team as we embark on a new year and anticipate several exciting milestones ahead,” said John McDonough, executive chairman and CESunbird Bio Presents New Clinical Data Demonstrating Proprietary Alpha Synuclein Blood-Based Biomarkers Could Accurately Diagnose Parkinson’s Disease
CAMBRIDGE, Mass. & SINGAPORE--(BUSINESS WIRE)--Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, announced new data demonstrating that the company’s blood-biomarker alpha synuclein (α-synuclein) signatures accurately detect the aggregation of α-synuclein in the brain from a simple blood draw. Results from the study, which will be shared in a poster presentation (#116) on OctobSunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based Diagnostic Platform in Alzheimer’s Disease and Other Neurological Disorders
CAMBRIDGE, Mass. and SINGAPORE--(BUSINESS WIRE)--Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, today announced the closing of a $14 million financing round backed by two new investors, Eli Lilly and Company and the strategic investment arm of the Singapore Economic Development Board, EDBI, as well as continued support from existing investors ClavystBio, Polaris Partners an
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Sunbird Bio
Sign Up For FreeTo access detailed company insights
Sunbird Bio is a biotech company specializing in the development of protein-based diagnostic tests aimed at enhancing the diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The company is pioneering blood-based diagnostic technology that allows for the direct detection of specific proteins associated wit... Read More
